A SYNERGISTIC PHARMACEUTICAL COMPOSITION USEFUL FOR THE TREATMENT OF LUNG CANCER

The present invention relates to a synergistic pharmaceutical composition comprising Compound C2 (Neo-isopulegol), C3 (Iso-pulegol) and C4 (Citronellol) derived from herbal seed extract of Litsea cubebp useful for the treatment of lung cancer. The present invention also relates to the activity of co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	BHATTACHARYA, SUSHMITA, CHATTERJEE, PRIYAJIT, BHATTACHARYA, SHELLEY, BHATTACHARYA, SAMIR, SEAL, SOMA, BHATTACHARYYA, PRANAB, RAM, MUKHERJEE, SANDEEP, BARUAH, PRANAB, KUMAR, BARUA, NABIN, CHANDRA, BHUYAN, MANTU, MOITRA, SUDIPTA, RAO, PARUCHURI, GANGADHAR, KUNDU, RAKESH, DASGUPTA, SUMAN
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a synergistic pharmaceutical composition comprising Compound C2 (Neo-isopulegol), C3 (Iso-pulegol) and C4 (Citronellol) derived from herbal seed extract of Litsea cubebp useful for the treatment of lung cancer. The present invention also relates to the activity of compounds C2 or C3 or C4 either alone or in combination in killing of A549 lung cancer cells. La présente invention concerne une composition pharmaceutique synergique comprenant un composé C2 (néo-isopulégol), C3 (isopulégol) et C4 (citronellol) dérivé d'un extrait de graines de plante médicinale de Litsea cubeba utile pour le traitement du cancer du poumon. La présente invention concerne également l'activité de composés C2 ou C3 ou C4, soit seuls, soit en association, pour détruire les cellules du cancer du poumon A549.